Exclusive: AstraZeneca signs off on a ‘carbon negative’ new biotech building for one of its latest buyouts
Breakthrough Properties is back keeping the dirt flying in biotech — this time breaking new ground in Amsterdam.
The commercial real estate alliance between Tishman Speyer, which built Pfizer’s new world headquarters in Manhattan, and Bellco Capital, the busy investment group Arie Belldegrun set up with his wife Rebecka 20 years ago, is now at work on a new, five-story, 55,000-square-foot building to house the growing team at Neogene, after AstraZeneca bought out the company last fall in a $320 million deal.
This article is for premium subscribers only
Upgrade to a premium subscription plan for unlimited access, and join our community of key biopharma players.